Artri Ajo King tablets
AustraliaArtri Ajo King tablets
Recalling Firm: TGA
Reason for Recall / Hazard
We are advising consumers that Artri Ajo King tablets may pose a serious risk to your health and should not be taken....
Product Description & Identification
We are advising consumers that Artri Ajo King tablets may pose a serious risk to your health and should not be taken.
Affected Products
Artri Ajo King tablets
Additional Source Details
| Field | Value |
|---|---|
| Guid › #text | https://www.tga.gov.au/node/558545 |
| Guid › @ is Perma Link | true |
| Link | https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/artri-ajo-king-tablets |
| Pub Date | Thu, 16 Apr 2026 00:00:00 +1000 |
| Extracted category | drugs |
Overview
- Recalling FirmTGA
- Risk LevelMedicines Safety Alert
- DistributionAustralia
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: TGA - Artri Ajo King tablets Check if your household is affected: https://therecallfile.com/recalls/artri-ajo-king-tablets/AU-TGA-558545
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Related Recalls
UKClass 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36
Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36
Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged r...
AustraliaGLP-1 RAs and rare, but severe, eye disorders
GLP-1 RAs and rare, but severe, eye disorders
Product warnings across the GLP-1 RA class of medicines have been updated due to the potential for these products to cause a rare, but severe, form of eye disorder....
UKClass 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release Tablets, EL(26)A/35
Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release Tablets, EL(26)A/35
Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of incorrect t...